Draft:aMoon
| Submission declined on 15 August 2022 by DoubleGrazing (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 20 March 2022 by Mako001 (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject. | |
| Submission declined on 8 July 2021 by Clearfrienda (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject. | |
Comment: The sources cited are interviews, bios, and mostly routine business reporting. The strongest one in terms of WP:GNG notability is the Jerusalem Post piece, but that is also at least partly an interview, and in any case isn't alone enough. DoubleGrazing (talk) 06:50, 15 August 2022 (UTC)
- Comment: The topic is definitely notable, the sources are good, but some parts of the article are written without a neutral point of view.
- Comment: The topic is definitely notable, the sources are good, but some parts of the article are written without a neutral point of view.
- Comment: This still isn't written in a neutral point of view, with some buzzwords and peacock phrases still present. Mako001 (C) (T) 🇺🇦 03:31, 20 March 2022 (UTC)
- Comment: The topic is definitely notable, the sources are good, but some parts of the article are written without a neutral point of view.
- Comment: The topic is definitely notable, the sources are good, but some parts of the article are written without a neutral point of view.
 | This is not a Wikipedia article: This is a workpage, a collection of material and work in progress that may or may not be incorporated into an article. It should not necessarily be considered factual or authoritative. |
| Company type | Privately held company |
|---|---|
| Industry | Venture Capital |
| Founded | 2017 |
| Headquarters | |
| Products | HealthTech venture capital fund |
| Website | https://www.amoon.fund/ |
aMoon is a venture capital firm focused on healthcare technology with over $1 B under management.[1] The firm was founded in 2017 in Tel Aviv, Israel, and has two investment funds: aMoon Growth and aMoon Velocity.[2]
History[edit]
aMoon was co-founded in 2017 by Marius Nacht and Dr. Yair Schindel.[3][4][5] It began as a single LP-investment fund and in early 2018, transitioned to an official venture capital structure. aMoon invests through two funds: aMoon Growth, which focuses on growth and mid-late stage companies; and aMoon Velocity, which focuses on early stage companies.[6]
Overview[edit]
aMoon Growth
aMoon Growth has investors from both Israel and abroad, including a partnership with Credit Suisse and Goldman Sachs.[7] The fund invests capital into companies that are in the mid-late-stages of their development cycle or the early-stages of commercial launch.[8] In March 2019, aMoon Growth raised $660M,[9] and in July 2020, it raised another $90M, bringing the total amount of the fund to $750M.[10][11][12] In 2021, the firm began raising aMoon Growth II, completing a first closing on the fund in October 2021 with undisclosed amounts.[8]
aMoon Velocity
aMoon Velocity focuses on investing in early stage companies. The fund invests as early as pre-seed and as late as round A. aMoon Velocity closed in December 2020 after raising $114M.[13]
References[edit]
- ^ "aMoon Fund Portfolio". www.cbinsights.com.
- ^ Ziv, Real (September 13, 2021). "Amon establishes a hedge fund". The Marker.
- ^ "Marius Nacht". Forbes. Retrieved 14 January 2021.
- ^ "Yair Schindel, MD". aMoon. Retrieved 13 January 2021.
- ^ Shulman, Sophie (21 February 2020). "Healthtech Is Israel's Next Growth Engine, Says Venture Capitalist". Calcalist. Retrieved 13 January 2021.
- ^ "Israel health fund aMoon II gets $600 million in investor commitments". Reuters. 9 January 2019. Retrieved 14 January 2021.
- ^ Shieber, Jonathan (6 March 2019). "A healthcare investment fund has become one of Israel's largest with a $660 million close". TechCrunch. Retrieved 13 January 2021.
- ^ a b Orbach, Meir (21 October 2021). "aMoon raising new massive healthtech fund". CTECH - www.calcalistech.com.
- ^ Weinreb, Gali (6 March 2019). "aMoon closes $660m Israeli health-tech VC fund". Globes. Retrieved 13 January 2021.
- ^ Benmeleh, Yaacov (22 July 2020). "Israel's Largest Health VC Ups Fund to $750 Million on Virus". Bloomberg. Retrieved 13 January 2021.
- ^ "Technology that heals". Jerusalem Post. 26 September 2018. Retrieved 14 January 2021.
- ^ Solomon, Shoshanna (22 July 2020). "Israel health fund aMoon II raises added $90 million amid pandemic". Times of Israel.
- ^ Ziv, Amitay (31 December 2020). ""Touching People's Lives": aMoon Velocity Trust Foundation kicks off with a $ 100 million fundraiser". TheMarker. Retrieved 13 January 2021.
External links[edit]
